AVEO Oncology Files Provisional Patent Applications for AV-353 for PAH Treatment
News, Pulmonary Hypertension
AVEO Oncology recently filed provisional patent applications with the United States Patent and Trademark Office (USPTO) covering composition of matter claims for AV-353, its Notch 3 inhibitory antibody. These are the ... Read more